Intended and Unintended Consequences of Constraining Clinician Prescribing: The Case of Antipsychotics

Critical Care Medicine

Volumn 44, Issue 10, 2016, Pages 1805-1807

  Devlin, John W ^a   Smithburger, Pamela ^b   Kane, Jason M ^c   Fraser, Gilles L ^d   Skrobik, Yoanna ^e  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d MAINE MEDICAL CENTER   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

antipsychotic agents; delirium; drug prescriptions; government regulations; intensive care; off label use

Indexed keywords

NEUROLEPTIC AGENT; OPIATE;

ANXIETY; BRADYCARDIA; CRITICALLY ILL PATIENT; DELIRIUM; DEMENTIA; DEPRESSION; EDITORIAL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MORTALITY; OPIATE ADDICTION; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; REIMBURSEMENT; AGED; CRITICAL ILLNESS; GOVERNMENT; OFF LABEL DRUG USE; PRACTICE GUIDELINE; UNITED STATES;

AGED; ANTIPSYCHOTIC AGENTS; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); CRITICAL ILLNESS; DELIRIUM; HUMANS; INTENSIVE CARE UNITS; OFF-LABEL USE; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84988422982     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002103     Document Type: Editorial

References (43)

1. Morandi A, Vasilevskis E, Pandharipande PP, et al: Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc 2013; 61: 1128-1134
2. Scales DC, Fisher HD, Li P, et al: Unintentional continuation of medications intended for acute illness after hospital discharge: A population-based cohort study. J Gen Intern Med 2015; 31: 196-202
3. Cullen DJ, Sweitzer BJ, Bates DW, et al: Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units. Crit Care Med 1997; 25: 1289-1297
4. Lat I, Micek S, Janzen J, et al: Off-label medication use in adult critical care patients. J Crit Care 2011; 26: 89-94
5. American Geriatrics Society 2015 Beers Criteria Update Expert Panel: American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015; 63: 2227-2246
6. Use of antipsychotics in older adults in the inpatient hospital setting. Available at: https: //www. cms. gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/MMS/CallforPublicComment. html#28. Accessed May 21, 2016
7. Requirements for hospital medication administration, particularly intravenous (IV) medications and post-operative care of patients receiving IV opioids. Available at: https: //www. cms. gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/ Survey-and-Cert-Letter-14-15. pdf. Accessed May 21, 2016
8. United Kingdom National Institute for Health and Care Excellence (NICE): Guidelines for delirium: Prevention, diagnosis and management. Available at: https: //www. nice. org. uk/guidance/cg103. Accessed May 21, 2016
9. American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults: American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc 2015; 63: 142-150
10. Herzig SJ, Rothberg MB, Guess JR, et al: Antipsychotic medication utilization in nonpsychiatric hospitalizations. J Hosp Med 2016; 11: 543-549
11. Marshall J, Herzig SJ, Howell MD, et al: Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care 2016; 33: 119-124
12. Rowe AS, Hamilton LA, Curtis RA, et al: Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit. J Crit Care 2015; 30: 1283-1286
13. Hwang YJ, Dixon SN, Reiss JP, et al: Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: A population-based cohort study. Ann Intern Med 2014; 161: 242-248
14. Trifirò G, Gambassi G, Sen EF, et al: Association of communityacquired pneumonia with antipsychotic drug use in elderly patients: A nested case-control study. Ann Intern Med 2010; 152: 418-25, W139
15. Wang PS, Schneeweiss S, Avorn J, et al: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-2341
16. Neufeld KM, Yue J, Robinson TN, et al: Antipsychotic medication for prevention and treatment of delirium in hospitalized patients: A systematic review and meta-analysis. J Am Geratr Soc 2016; 64: 705-714
17. Serafim RB, Bozza FA, Soares M, et al: Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review. J Crit Care 2015; 30: 799-807
18. Devlin JW, Barletta JF: Principles of drug dosing in the critically ill. In: Critical Care Medicine: Principles of Diagnosis and Management in the Adult. Third Edition. Parillo JW, Dellinger RP (Eds). Philadelphia, PA: Mosby-Elsevier, 2008, pp 343-376
19. Salluh JI, Wang H, Schneider EB, et al: Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015; 350: h2538
20. Breitbart W, Gibson C, Tremblay A: The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002; 43: 183-194
21. Jackson JC, Pandharipande PP, Girard TD, et al: Bringing to light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors (BRAIN-ICU) study investigators: Depression, posttraumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: A longitudinal cohort study. Lancet Respir Med 2014; 2: 369-379
22. Wolters AE, Peelen LM, Welling MC, et al: Long-term mental health problems after delirium in the ICU. Crit Care Med 2016 Aug 2. [Epub ahead of print]
23. Trogrli Z, van der Jagt M, Bakker J, et al: A systematic review of implementation strategies for assessment, prevention, and management of ICU delirium and their effect on clinical outcomes. Crit Care 2015; 19: 157
24. Centers for Medicare & Medicaid Services: Fact sheets. CMS proposes additions to list of hospital-acquired conditions for fiscal year 2009. Available at: http: //www. cms. gov/apps/media/press/factsheet. asp. Accessed May 21 2016
25. Swan JT, Fitousis K, Hall JB, et al: Antipsychotic use and diagnosis of delirium in the intensive care unit. Crit Care 2012; 16: R84
26. Smithburger PL, Buckley MS, Culver MA, et al: A multicenter evaluation of off-label medication use and associated adverse drug reactions in adult medical ICUs. Crit Care Med 2015; 43: 1612-1621
27. American Psychiatric Association: Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999; 156: 1-20
28. Barr J, Fraser GL, Puntillo K, et al: Clinical practice guidelines for the management of pain, agitation and delirium in adult ICU patients. Crit Care Med 2013; 41: 263-306
29. Caplan JP: Diagnosis and treatment of agitation and delirium in the intensive care unit patient. In: Irwin and Rippe's Intensive Care Medicine: Edition 7. Irwin RS, Rippe JM (Eds). Philadelphia, PA: Lippincott, William & Wilkins, 2012, pp 2073-2079
30. Devlin, JW, Roberts R, Fong JJ, et al: Efficacy and safety of quetiapine for delirium in the ICU: A randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38: 419-427
31. Girard TD, Pandharipande PP, Carson SS, et al: Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38: 428-437
32. Page VJ, Ely EW, Gates S, et al: Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): A randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2013; 1: 515-523
33. Al-Qadheeb NS, Skrobik Y, Schumaker G, et al: Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study. Crit Care Med 2016; 44: 583-591
34. Balas MC, Vasilevskis EE, Olsen KM, et al: Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/ management, and early exercise/mobility bundle. Crit Care Med 2014; 42: 1024-1036
35. Smith BS, Yogaratnam D, Levasseur-Franklin KE, et al: Introduction to drug pharmacokinetics in the critically ill patient. Chest 2012; 141: 1327-1336
36. Devlin JW, Skrobik Y: Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role? Harv Rev Psychiatry 2011; 19: 59-67
37. van den Boogaard M, Slooter AJ, Brüggemann RJ, et al: Prevention of ICU delirium and delirium-related outcome with haloperidol: A study protocol for a multicenter randomized controlled trial. Trials 2013; 14: 400
38. The modifying the impact of ICU-associated neurological dysfunction USA (MIND-USA) study. Available at: https: //clinicaltrials. gov/ct2/ show/NCT01211522?term=MIND+USA&rank. Accessed May 21, 2016
39. Reade MC, Eastwood GM, Bellomo R, et al: DahLIA Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group: Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: A randomized clinical trial. JAMA 2016; 315: 1460-1468
40. Kondili E, Alexopoulou C, Xirouchaki N, et al: Effects of propofol on sleep quality in mechanically ventilated critically ill patients: A physiological study. Intensive Care Med 2012; 38: 1640-1646
41. Oto J, Yamamoto K, Koike S, et al: Effect of daily sedative interruption on sleep stages of mechanically ventilated patients receiving midazolam by infusion. Anaesth Intensive Care 2011; 39: 392-400
42. Society of Critical Care Medicine ICU Liberation Campaign. Available at: http: //www. iculiberation. org. Accessed May 21, 2016
43. AGS/NIA Delirium Conference Writing Group, Planning Committee and Faculty: The American Geriatrics Society/National Institute on Aging Bedside-to-Benchmark Conference: Research agenda on delirium in older adults. J Am Geriatr Soc 2015; 63: 843-852